The Levels of Expression of Galectin-3, But Not of Galectin-1 and Galectin-8, Correlate With Apoptosis in Human Cholesteatomas
Objectives To investigate whether galectins 1, 3, and 8 are expressed in human cholesteatomas and whether any such expression does correlate with the level of apoptosis, which is, as we have previously shown, predictive of recurrence. 7 Study Design The analysis of 52 cholesteatomas resected by the...
Saved in:
Published in: | The Laryngoscope Vol. 111; no. 6; pp. 1042 - 1047 |
---|---|
Main Authors: | , , , , , , , , , , |
Format: | Journal Article |
Language: | English |
Published: |
Hoboken, NJ
John Wiley & Sons, Inc
01-06-2001
Wiley-Blackwell |
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Objectives To investigate whether galectins 1, 3, and 8 are expressed in human cholesteatomas and whether any such expression does correlate with the level of apoptosis, which is, as we have previously shown, predictive of recurrence. 7
Study Design The analysis of 52 cholesteatomas resected by the same surgeon by means of canal wall up and canal wall down procedures.
Methods The immunohistochemical levels of expression of galectins 1, 3, and 8 were quantitatively determined (using computer‐assisted microscopy) on conventional histological slides by means of specific anti–galectin‐1, anti–galectin‐3, and anti–galectin‐8 antibodies. The level of apoptosis in each cholesteatoma under study had already been determined 7 by means of the in situ labeling of nuclear DNA fragmentation (Tolt‐mediated dUTP nick end labeling [TUNEL] staining).
Results Galectin‐1 was expressed markedly in both the epithelial and the connective tissue areas of all the cholesteatomas under study. The levels of expression of galectin‐3 and galectin‐8 were considerably lower than that of galectin‐1. The level of expression of galectin‐3 correlated both highly and positively with the level of apoptosis.
Conclusions An upregulation of galectin‐3 (known to have an antiapoptotic and antianoikis effect in certain model systems) expression, which is associated with pronounced apoptotic activity, could have a physiologically protective effect against the characteristically substantial apoptotic features occurring in recurrent cholesteatomas. |
---|---|
Bibliography: | istex:3FC19C5CB26F7C26F0A64D1E89FD50AE7E495AEA ark:/67375/WNG-MBS6GB8G-Z ArticleID:LARY5541110620 Supported by grants awarded by the Fonds de la Recherche Scientifique Médicale (FRSM), Brussels, Belgium. Doctors Decaestecker and Kiss are with the Fonds National de la Recherche Scientifique (FNRS), Brussels, Belgium. ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ISSN: | 0023-852X 1531-4995 |
DOI: | 10.1097/00005537-200106000-00020 |